CIK 0000925741 · Non-accelerated filer<br>Smaller reporting company
BioCardia, Inc.
Sign in to watch- Ticker
- BCDA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 232753988
- Phone
- 650-226-0123
- Business address
- 320 SOQUEL WAY, SUNNYVALE, CA, 94085
- Former names
- Tiger X Medical, Inc., Cardo Medical, Inc., CLICKNSETTLE COM INC, NAM CORP
- 4 Open-market buy President and CEO bought 500 shares at $0.95 ($475)
- 4 Open-market buy President and CEO bought 1,000 shares at $1.03 ($1,030)
- 4 Open-market buy President and CEO bought 1,900 shares at $1.05 ($1,995)
- 4 Open-market buy President and CEO bought 800 shares at $1.09 ($872)
- 4 Open-market buy President and CEO bought 5,400 shares at $0.93 ($5,022)
- 4 Open-market buy President and CEO bought 1,900 shares at $0.92 ($1,748)
- 4 Open-market buy President and CEO bought 5,000 shares at $0.78 ($3,900)
- 4 Open-market buy President and CEO bought 500 shares at $0.83 ($415)
- 4 Open-market buy President and CEO bought 4,300 shares at an average $0.87 ($3,754)
- 4 Open-market buy President and CEO bought 7,500 shares at an average $0.96 ($7,175)
- 4 Open-market buy President and CEO bought 5,400 shares at $0.96 ($5,208)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President and CEO gave up 54,606 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 23,125 shares (to pay taxes)
- 4 Shares withheld for taxes Senior Vice President, Devices gave up 17,269 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 1 of 23 · 442 filings